Optimi Health Begins Cultivation Of Natural Psilocybin For Use In Clinical Trials
Ryan Allway March 18th, 2022 Psychedelics, Top News VANCOUVER, British Columbia, March 18, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has commenced the cultivation of natural GMP-grade psilocybin mushrooms at its Princeton, British... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )